Valirx (VAL) RNS Announcements

Add to Alert list
Date Time Source Announcement
23 Sep 2020 07:00 AM
RNS
Share Price Movement / Exercise of Warrant
22 Sep 2020 04:40 PM
RNS
Second Price Monitoring Extn
22 Sep 2020 04:36 PM
RNS
Price Monitoring Extension
14 Sep 2020 07:00 AM
RNS
Exercise of Warrants and Warrant Update
09 Sep 2020 06:01 PM
RNS
Holding(s) in Company
08 Sep 2020 04:04 PM
RNS
Holding(s) in Company
07 Sep 2020 01:30 PM
RNS
Exercise of Warrant
07 Sep 2020 07:00 AM
RNS
Half-year Report
03 Sep 2020 04:40 PM
RNS
Second Price Monitoring Extn
03 Sep 2020 04:35 PM
RNS
Price Monitoring Extension
01 Sep 2020 07:00 AM
RNS
Total Voting Rights
28 Aug 2020 07:00 AM
RNS
Exercise of Warrants
20 Aug 2020 12:45 PM
RNS
Holding(s) in Company
19 Aug 2020 07:00 AM
RNS
Block Listing Application and Company Update
18 Aug 2020 07:00 AM
RNS
Holding(s) in Company
14 Aug 2020 03:57 PM
RNS
Holding(s) in Company
10 Aug 2020 03:05 PM
RNS
Holding(s) in Company
07 Aug 2020 02:20 PM
RNS
Director/PDMR Shareholding
05 Aug 2020 03:14 PM
RNS
Holding(s) in Company
03 Aug 2020 02:49 PM
RNS
Holding(s) in Company
30 Jul 2020 11:05 AM
RNS
Second Price Monitoring Extn
30 Jul 2020 11:00 AM
RNS
Price Monitoring Extension
24 Jul 2020 12:38 PM
RNS
Broker Option - Fully Subscribed
23 Jul 2020 04:41 PM
RNS
Second Price Monitoring Extn
23 Jul 2020 04:36 PM
RNS
Price Monitoring Extension
23 Jul 2020 03:02 PM
RNS
Fundraise
23 Jul 2020 01:00 PM
RNS
Result of AGM
23 Jul 2020 07:00 AM
RNS
AGM Statement
17 Jul 2020 09:14 AM
RNS
AGM Arrangements
06 Jul 2020 07:00 AM
RNS
Corporate Update
01 Jul 2020 07:00 AM
RNS
Notice of AGM
01 Jul 2020 07:00 AM
RNS
Final Results
29 Jun 2020 11:44 AM
RNS
Appointment of Director
24 Jun 2020 01:24 PM
RNS
Holding(s) in Company
23 Jun 2020 05:26 PM
RNS
Holding(s) in Company
22 Jun 2020 02:06 PM
RNS
Second Price Monitoring Extn
22 Jun 2020 02:00 PM
RNS
Price Monitoring Extension
16 Jun 2020 07:00 AM
RNS
Corporate Update
11 Jun 2020 07:00 AM
RNS
New shareholder communication process
08 Jun 2020 11:08 AM
RNS
Correction Directorate Change & Audited accounts
08 Jun 2020 07:00 AM
RNS
Directorate Change & Audited accounts extension
02 Jun 2020 09:56 AM
RNS
Holding(s) in Company
02 Jun 2020 09:05 AM
RNS
Second Price Monitoring Extn
02 Jun 2020 09:00 AM
RNS
Price Monitoring Extension
02 Jun 2020 07:41 AM
RNS
Collaboration Agreement Signed
29 May 2020 07:00 AM
RNS
Patent Assignment
27 May 2020 01:34 PM
RNS
Holding(s) in Company
27 May 2020 09:57 AM
RNS
Proposed Board Change
27 May 2020 08:54 AM
RNS
Holding(s) in Company
27 May 2020 07:00 AM
RNS
Holding(s) in Company

ValiRx PLC: A Biotech Innovator on the London Stock Exchange (LSE)

ValiRx PLC, known by its ticker symbol VAL, is a trailblazer in the biotechnology sector. Its performance on the London Stock Exchange (LSE) has been remarkable, with the ValiRx share price reflecting the company's consistent growth and success.

As a member of the LSE, ValiRx PLC aligns with the London Stock Exchange Group's (LSEG) mission of supporting innovative and growing businesses. The LSEG recognises ValiRx PLC as a significant player, contributing to the robust and diverse ecosystem of the LSE.

The ValiRx share price on the LSE not only underscores its financial stability but also its strategic vision in the biotechnology industry. ValiRx PLC's journey on the LSE is a testament to its robust business model and its ability to create value for its stakeholders.

In conclusion, ValiRx PLC's association with the LSE and LSEG symbolises its commitment to growth, innovation, and value creation. As ValiRx PLC continues to thrive on the LSE, it sets the bar high for the biotechnology industry, contributing to the dynamic and diverse ecosystem of the LSEG. With its focus on cancer therapeutics, ValiRx is a key player in the healthcare sector, making strides in medical research and development.

UK 100

Latest directors dealings